BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 16452213)

  • 1. Mutations in the PI3K/PTEN/TSC2 pathway contribute to mammalian target of rapamycin activity and increased translation under hypoxic conditions.
    Kaper F; Dornhoefer N; Giaccia AJ
    Cancer Res; 2006 Feb; 66(3):1561-9. PubMed ID: 16452213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Akt-dependent proapoptotic effects of dietary restriction on late-stage management of a phosphatase and tensin homologue/tuberous sclerosis complex 2-deficient mouse astrocytoma.
    Marsh J; Mukherjee P; Seyfried TN
    Clin Cancer Res; 2008 Dec; 14(23):7751-62. PubMed ID: 19047102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Androgens induce prostate cancer cell proliferation through mammalian target of rapamycin activation and post-transcriptional increases in cyclin D proteins.
    Xu Y; Chen SY; Ross KN; Balk SP
    Cancer Res; 2006 Aug; 66(15):7783-92. PubMed ID: 16885382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutual regulation of hypoxia-inducible factor and mammalian target of rapamycin as a function of oxygen availability.
    Knaup KX; Jozefowski K; Schmidt R; Bernhardt WM; Weidemann A; Juergensen JS; Warnecke C; Eckardt KU; Wiesener MS
    Mol Cancer Res; 2009 Jan; 7(1):88-98. PubMed ID: 19147540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of insulin-like growth factor signaling induces apoptotic cell death under prolonged hypoxia by enhancing endoplasmic reticulum stress response.
    Endo H; Murata K; Mukai M; Ishikawa O; Inoue M
    Cancer Res; 2007 Sep; 67(17):8095-103. PubMed ID: 17804721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NVP-BEZ235, a dual PI3K/mTOR inhibitor, prevents PI3K signaling and inhibits the growth of cancer cells with activating PI3K mutations.
    Serra V; Markman B; Scaltriti M; Eichhorn PJ; Valero V; Guzman M; Botero ML; Llonch E; Atzori F; Di Cosimo S; Maira M; Garcia-Echeverria C; Parra JL; Arribas J; Baselga J
    Cancer Res; 2008 Oct; 68(19):8022-30. PubMed ID: 18829560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective inhibition of growth of tuberous sclerosis complex 2 null cells by atorvastatin is associated with impaired Rheb and Rho GTPase function and reduced mTOR/S6 kinase activity.
    Finlay GA; Malhowski AJ; Liu Y; Fanburg BL; Kwiatkowski DJ; Toksoz D
    Cancer Res; 2007 Oct; 67(20):9878-86. PubMed ID: 17942919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mammalian target of rapamycin: discovery of rapamycin reveals a signaling pathway important for normal and cancer cell growth.
    Gibbons JJ; Abraham RT; Yu K
    Semin Oncol; 2009 Dec; 36 Suppl 3():S3-S17. PubMed ID: 19963098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of mammalian target of rapamycin activity in PTEN-inactive prostate cancer cells by I kappa B kinase alpha.
    Dan HC; Adli M; Baldwin AS
    Cancer Res; 2007 Jul; 67(13):6263-9. PubMed ID: 17616684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet-derived growth factor-induced p42/44 mitogen-activated protein kinase activation and cellular growth is mediated by reactive oxygen species in the absence of TSC2/tuberin.
    Finlay GA; Thannickal VJ; Fanburg BL; Kwiatkowski DJ
    Cancer Res; 2005 Dec; 65(23):10881-90. PubMed ID: 16322235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survival signaling by Notch1: mammalian target of rapamycin (mTOR)-dependent inhibition of p53.
    Mungamuri SK; Yang X; Thor AD; Somasundaram K
    Cancer Res; 2006 May; 66(9):4715-24. PubMed ID: 16651424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Silencing mammalian target of rapamycin signaling by small interfering RNA enhances rapamycin-induced autophagy in malignant glioma cells.
    Iwamaru A; Kondo Y; Iwado E; Aoki H; Fujiwara K; Yokoyama T; Mills GB; Kondo S
    Oncogene; 2007 Mar; 26(13):1840-51. PubMed ID: 17001313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A potential mechanism for short time exposure to hypoxia-induced DNA synthesis in primary cultured chicken hepatocytes: Correlation between Ca(2+)/PKC/MAPKs and PI3K/Akt/mTOR.
    Lee SH; Lee MY; Lee JH; Han HJ
    J Cell Biochem; 2008 Aug; 104(5):1598-611. PubMed ID: 18646054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of PI3K/mTOR pathway rescues LLC cells from cell death induced by hypoxia.
    Hamanaka Y; Mukai M; Shimamura M; Kitagawa T; Nishida T; Isohashi F; Ito T; Nishizawa Y; Tatsuta M; Matsuda H; Inoue M
    Biochem Biophys Res Commun; 2005 Apr; 330(1):318-26. PubMed ID: 15781267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Silibinin inhibits hypoxia-inducible factor-1alpha and mTOR/p70S6K/4E-BP1 signalling pathway in human cervical and hepatoma cancer cells: implications for anticancer therapy.
    GarcĂ­a-Maceira P; Mateo J
    Oncogene; 2009 Jan; 28(3):313-24. PubMed ID: 18978810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antagonism of the mammalian target of rapamycin selectively mediates metabolic effects of epidermal growth factor receptor inhibition and protects human malignant glioma cells from hypoxia-induced cell death.
    Ronellenfitsch MW; Brucker DP; Burger MC; Wolking S; Tritschler F; Rieger J; Wick W; Weller M; Steinbach JP
    Brain; 2009 Jun; 132(Pt 6):1509-22. PubMed ID: 19416948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of microtubule-dependent protein transport by the TSC2/mammalian target of rapamycin pathway.
    Jiang X; Yeung RS
    Cancer Res; 2006 May; 66(10):5258-69. PubMed ID: 16707451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Handicapping the race to develop inhibitors of the phosphoinositide 3-kinase/Akt/mammalian target of rapamycin pathway.
    Granville CA; Memmott RM; Gills JJ; Dennis PA
    Clin Cancer Res; 2006 Feb; 12(3 Pt 1):679-89. PubMed ID: 16467077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nitric oxide in physiologic concentrations targets the translational machinery to increase the proliferation of human breast cancer cells: involvement of mammalian target of rapamycin/eIF4E pathway.
    Pervin S; Singh R; Hernandez E; Wu G; Chaudhuri G
    Cancer Res; 2007 Jan; 67(1):289-99. PubMed ID: 17210710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tuberous sclerosis: a GAP at the crossroads of multiple signaling pathways.
    Kwiatkowski DJ; Manning BD
    Hum Mol Genet; 2005 Oct; 14 Spec No. 2():R251-8. PubMed ID: 16244323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.